XML 72 R60.htm IDEA: XBRL DOCUMENT
v3.20.4

Note 10 - Commitments and Contingencies (Details Textual) shares in Thousands |  |  |  | 1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
May 29, 2020 USD ($) | Mar. 31, 2020 USD ($) shares | Nov. 01, 2019 USD ($) | Jan. 31, 2020 USD ($) | May 31, 2016 USD ($) | Dec. 31, 2020 USD ($) | Dec. 31, 2019 USD ($) | Dec. 31, 2020 USD ($) | Dec. 31, 2019 USD ($) | Jun. 30, 2020 USD ($) | Jun. 30, 2019 | Jun. 30, 2018 | May 01, 2020 USD ($) | Feb. 14, 2020 USD ($) | Feb. 28, 2015 USD ($)
Gain (Loss) from Change in Fair Value of CVR |  |  |  |  |  |  |  | $ (899,987) |  |  |  |  |  |  |
Contractual Obligation, Total |  |  |  |  |  | $ 38,320,000 |  | 38,320,000 |  |  |  |  |  |  |
Tris Pharma, Inc. [Member] | Karbinal Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Supply and Distribution Commitment, Period (Year) |  |  | 20 years |  |  |  |  |  |  |  |  |  |  |  |
Supply and Distribution Commitment, Total Royalty, Percentage of Net Sales |  |  | 23.50% |  |  |  |  |  |  |  |  |  |  |  |
Supply and Distribution Commitment, Third Party, Royalty, Percentage of Net Sales |  |  | 8.50% |  |  |  |  |  |  |  |  |  |  |  |
Supply and Distribution Commitment, Royalty, Percentage of Net Sales |  |  |  |  |  |  |  |  |  |  | 15.00% | 15.00% |  |  |
Supply and Distribution Agreement, Maximum Yearly Make-whole Payment |  |  | $ 2,100,000 |  |  |  |  |  |  |  |  |  |  |  |
Supply and Distribution Agreement, Minimum Sales Per Year |  |  | 70,000 |  |  |  |  |  |  |  |  |  |  |  |
Supply and Distribution Agreement, Make-whole Payment Per Unit for Sales Under Minimum |  |  | $ 30 |  |  |  |  |  |  |  |  |  |  |  |
Supply and Distribution Agreement, Maximum Milestone Obligations |  |  | 3,000,000 |  |  |  |  |  |  |  |  |  |  |  |
Supply and Distribution Agreement, First Milestone, Minimum Net Revenues |  |  | 40,000,000 |  |  |  |  |  |  |  |  |  |  |  |
Innovus Pharmaceuticals [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock Issued During Period, Shares, Contingent Value Rights (in shares) | shares |  | 120 |  |  |  |  |  |  |  |  |  |  |  |  |
Stock Issued During Period, Value, Contingent Value Rights |  | $ 2,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Contingent Value Rights, First Revenue Milestone |  | 24,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Gain (Loss) from Change in Fair Value of CVR |  | $ 300,000 |  |  |  | (100,000) | $ (100,000) | (800,000) | $ (800,000) | $ 300,000 |  |  |  |  |
Business Combination, Contingent Consideration, Liability, Total |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 200,000 |
Novalere [Member] | Innovus Pharmaceuticals [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition, Contingent Consideration, Number of Payments |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5
Business Acquisition, Contingent Consideration, Payment Upon Each Sales Milestone |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 500,000
Business Combination, Contingent Consideration, Liability, Total |  |  |  |  |  | 200,000 |  | 200,000 |  |  |  |  |  |  |
Prescription Database [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Unrecorded Unconditional Purchase Obligation, Total |  |  |  |  | $ 1,600,000 |  |  |  |  |  |  |  |  |  |
Unrecorded Unconditional Purchase Obligation, Term (Year) |  |  |  |  | 3 years |  |  |  |  |  |  |  |  |  |
Contractual Obligation, Total |  |  |  |  |  | 1,278,000 |  | 1,278,000 |  |  |  |  |  |  |
Prescription Database [Member] | The Pediatric Portfolio [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Unrecorded Unconditional Purchase Obligation, Total |  |  |  | $ 600,000 |  |  |  |  |  |  |  |  |  |  |
First Pediatric Portfolio Fixed Obligation [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contractual Obligation, Monthly Payment |  |  | 86,840 |  |  |  |  |  |  |  |  |  |  |  |
Contractual Obligation, Balloon Payment |  |  | 15,000,000 |  |  |  |  |  |  |  |  |  |  |  |
Repayments of Fixed Obligation | $ 15,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Second Pediatric Portfolio Fixed Obligation [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contractual Obligation, Monthly Payment |  |  | $ 100,000 |  |  |  |  |  |  |  |  |  |  |  |
Payments for Fixed Obligations to Investor |  |  |  | $ 210,767 |  |  |  |  |  |  |  |  |  |  |
Inventories [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contractual Obligation, Total |  |  |  |  |  | 1,717,000 |  | 1,717,000 |  |  |  |  |  |  |
Inventories [Member] | Hikma Pharmaceuticals USA, Inc. [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Unrecorded Unconditional Purchase Obligation, Total |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,000,000 |  |
Product Milestone Payments [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contractual Obligation, Total |  |  |  |  |  | $ 3,000,000 |  | $ 3,000,000 |  |  |  |  |  |  |

X
- Definition The number of payments for contingent consideration under the business acquisition. + References No definition available. + Details
Name: | aytu_BusinessAcquisitionContingentConsiderationNumberOfPayments
Namespace Prefix: | aytu_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition The amount of payment per each sales milestone of contingent consideration of the business acquaition. + References No definition available. + Details
Name: | aytu_BusinessAcquisitionContingentConsiderationPaymentUponEachSalesMilestone
Namespace Prefix: | aytu_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The first revenue milestone for contingent value rights of the business acquisition. + References No definition available. + Details
Name: | aytu_BusinessCombinationContingentValueRightsFirstRevenueMilestone
Namespace Prefix: | aytu_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of balloon payment under contractual obligation. + References No definition available. + Details
Name: | aytu_ContractualObligationBalloonPayment
Namespace Prefix: | aytu_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of monthly payment under contractual obligation. + References No definition available. + Details
Name: | aytu_ContractualObligationMonthlyPayment
Namespace Prefix: | aytu_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of gain (loss) from change in fair value of CVR. + References No definition available. + Details
Name: | aytu_GainLossFromChangeInFairValueOfCVR
Namespace Prefix: | aytu_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of cash outflow for fixed obligation to investor. + References No definition available. + Details
Name: | aytu_PaymentsForFixedObligationsToInvestor
Namespace Prefix: | aytu_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of cash outflow for fixed obligations during the period. + References No definition available. + Details
Name: | aytu_RepaymentsOfFixedObligation
Namespace Prefix: | aytu_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The number of shares of stock issued during the period for contingent value rights. + References No definition available. + Details
Name: | aytu_StockIssuedDuringPeriodSharesContingentValueRights
Namespace Prefix: | aytu_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The value of stock issued during the period for contingent value rights. + References No definition available. + Details
Name: | aytu_StockIssuedDuringPeriodValueContingentValueRights
Namespace Prefix: | aytu_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of net revenues to be reached to trigger the first milestone obligation of the supply and distribution agreement. + References No definition available. + Details
Name: | aytu_SupplyAndDistributionAgreementFirstMilestoneMinimumNetRevenues
Namespace Prefix: | aytu_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of make-whole payment per unit for sales under the minimum units for the supply and distribution agreement. + References No definition available. + Details
Name: | aytu_SupplyAndDistributionAgreementMakewholePaymentPerUnitForSalesUnderMinimum
Namespace Prefix: | aytu_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The maximum amount of milestone obligations of the supply and distribution agreement. + References No definition available. + Details
Name: | aytu_SupplyAndDistributionAgreementMaximumMilestoneObligations
Namespace Prefix: | aytu_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The maximum amount of make-whole payment per year under supply and distribution agreement. + References No definition available. + Details
Name: | aytu_SupplyAndDistributionAgreementMaximumYearlyMakewholePayment
Namespace Prefix: | aytu_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Th minimum amount of units to be sold per year under supply and distribution agreement. + References No definition available. + Details
Name: | aytu_SupplyAndDistributionAgreementMinimumSalesPerYear
Namespace Prefix: | aytu_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition Period covered by the supply and distribution commitment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | aytu_SupplyAndDistributionCommitmentPeriod
Namespace Prefix: | aytu_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The percentage of net sales to be paid for royalties under supply and distribution agreement. + References No definition available. + Details
Name: | aytu_SupplyAndDistributionCommitmentRoyaltyPercentageOfNetSales
Namespace Prefix: | aytu_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The percentage of net sales to be paid by third party for royalties under supply and distribution agreement. + References No definition available. + Details
Name: | aytu_SupplyAndDistributionCommitmentThirdPartyRoyaltyPercentageOfNetSales
Namespace Prefix: | aytu_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The percentage of net sales that is to be paid in total for royalties under the supply and distribution agreement. + References No definition available. + Details
Name: | aytu_SupplyAndDistributionCommitmentTotalRoyaltyPercentageOfNetSales
Namespace Prefix: | aytu_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of liability recognized arising from contingent consideration in a business combination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 35 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments. + References No definition available. + Details
Name: | us-gaap_ContractualObligation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of the unrecorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 440 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308 + Details
Name: | us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Term of the unrecognized unconditional purchase obligation, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 440 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308 + Details
Name: | us-gaap_UnrecordedUnconditionalPurchaseObligationTerm
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=aytu_TrisPharmaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=aytu_KarbinalAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=aytu_InnovusPharmaceuticalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=aytu_NovalereMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=aytu_InnovusPharmaceuticalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis=aytu_PrescriptionDatabaseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=aytu_ThePediatricPortfolioMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis=aytu_FirstPediatricPortfolioFixedObligationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis=aytu_SecondPediatricPortfolioFixedObligationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis=us-gaap_InventoriesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=aytu_HikmaPharmaceuticalsUsaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_UnrecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis=aytu_ProductMilestonePaymentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |